#pharmaceutical-investment

#pharmaceutical-investment

price increases are going to be a necessary part

Patrick Vallance, a former executive at drugmaker GSK, said the country needed to increase spending on medicines and reverse a decade of declining investment. We are determined to solve this, Lord Vallance told the Commons science committee. This is not something [where] we're sitting saying let's watch the decline of the industry. That's what's happened for the past 10 years. We must not do that. We have to act. Now is a pivotal moment to try to get this right.

We've still got the best universities, we've got some of the best scientists in the world, but it's not a good place to do the development work for medicines. It's an expensive place to operate, and it's a terrible place to sell medicines.